RNF25 Activators
RNF25 Activators belong to a distinct chemical class known for their ability to modulate the activity of the E3 ubiquitin ligase enzyme called Ring Finger Protein 25 (RNF25). This class of compounds is primarily characterized by their structural features and functional mechanisms that facilitate the activation of RNF25. RNF25 is a crucial component of the ubiquitin-proteasome system, which plays a fundamental role in protein degradation and turnover within cells. Its activation has garnered significant interest in the realm of molecular biology and cellular physiology due to its impact on protein homeostasis.
RNF25 Activators typically possess chemical moieties that interact with specific binding sites on RNF25, leading to conformational changes that enhance its enzymatic activity. These activators can act as allosteric modulators, promoting the ubiquitination of target proteins by RNF25. The ubiquitination process, catalyzed by RNF25, marks proteins for degradation, thereby regulating various cellular processes, including signal transduction, cell cycle progression, and DNA repair. The discovery and characterization of RNF25 Activators have provided valuable insights into the intricate mechanisms governing protein degradation and turnover, shedding light on their roles in cellular homeostasis and disease pathogenesis. Researchers continue to explore the chemical diversity and pharmacological properties of RNF25 Activators.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
A proteasome inhibitor that can indirectly upregulate RNF25 activity by preventing the degradation of its substrates. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
It modulates the activity of E3 ubiquitin ligases, which could indirectly affect RNF25. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Another proteasome inhibitor that may indirectly impact RNF25 function by altering the stability of its substrates. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
An inhibitor of the MDM2-p53 interaction, which could indirectly influence RNF25 through p53-dependent mechanisms. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
An inhibitor of BET bromodomain proteins, which may have downstream effects on RNF25 activity via transcriptional regulation. | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $50.00 $374.00 $2071.00 | 18 | |
it can influence protein degradation pathways and potentially affect RNF25. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
A chemotherapeutic agent that can impact protein ubiquitination and degradation, possibly affecting RNF25 function. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
A natural compound with anti-inflammatory properties that could modulate the ubiquitin-proteasome system and potentially impact RNF25 activity. | ||||||
MLN 4924 | 905579-51-3 | sc-484814 | 1 mg | $286.00 | 1 | |
An inhibitor of the neddylation pathway, which is associated with the regulation of certain E3 ligases, including RNF25. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $67.00 $156.00 | 16 | |
An Hsp90 inhibitor that can disrupt protein folding and stability, indirectly impacting RNF25 substrates. | ||||||